Fragmin

Fragmin is a brand name of dalteparin, approved by the FDA in the following formulation(s):

FRAGMIN (dalteparin sodium - injectable; subcutaneous)

• 
  Manufacturer: EISAI INC
  
  Approval date: December 22, 1994
  
  Strength(s): 2,500IU/0.2ML (12,500IU/ML)
  


• 
  Manufacturer: EISAI INC
  
  Approval date: March 18, 1996
  
  Strength(s): 5,000IU/0.2ML (25,000IU/ML)
  


• 
  Manufacturer: EISAI INC
  
  Approval date: January 30, 1998
  
  Strength(s): 10,000IU/ML (10,000IU/ML)
  


• 
  Manufacturer: EISAI INC
  
  Approval date: April 4, 2002
  
  Strength(s): 7,500IU/0.3ML (25,000IU/ML), 95,000IU/3.8ML (25,000IU/ML) ^[RLD], 95,000IU/9.5ML (10,000IU/ML)
  


• 
  Manufacturer: EISAI INC
  
  Approval date: May 1, 2007
  
  Strength(s): 10,000IU/0.4ML (25,000IU/ML), 12,500IU/0.5ML (25,000IU/ML), 15,000IU/0.6ML (25,000IU/ML), 18,000IU/0.72ML (25,000IU/ML)
  

Has a generic version of Fragmin been approved?

No. There is currently no therapeutically equivalent version of Fragmin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Fragmin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Fragmin.

See also...

• Fragmin Consumer Information (Drugs.com)
• Fragmin Consumer Information (Wolters Kluwer)
• Fragmin Consumer Information (Cerner Multum)
• Fragmin Advanced Consumer Information (Micromedex)
• Fragmin AHFS DI Monographs (ASHP)
• Dalteparin Consumer Information (Wolters Kluwer)
• Dalteparin Consumer Information (Cerner Multum)
• Dalteparin Subcutaneous Advanced Consumer Information (Micromedex)
• Dalteparin Sodium AHFS DI Monographs (ASHP)